In recent years, several new biomarkers supplementing the role of prostate-specific antigen
(PSA) have become available for men with prostate cancer. Although widely used in an ad …

CONTEXT: Prostate cancer (PCa) remains an increasingly common malignancy worldwide.
The optimal management of clinically localized, early-stage disease remains unknown, and …

Abstract Background The Prostate Cancer Research International Active Surveillance
(PRIAS) study was initiated a decade ago to study the most optimal selection and follow-up …

BACKGROUND: Overdiagnosis and subsequent overtreatment are important side effects of
screening for, and early detection of, prostate cancer (PCa). Active surveillance (AS) is of …

Purpose We assessed outcomes of men with prostate cancer enrolled in active surveillance.
Patients and Methods Since 1995, a total of 769 men diagnosed with prostate cancer have …

Background Active surveillance (AS) aims to allow men with favourable-risk, localised
prostate cancer to avoid unnecessary treatment. Objective To describe the clinical outcomes …

Objectives To identify areas of agreement and disagreement in the implementation of multi‐
parametric magnetic resonance imaging (mp MRI) of the prostate in the diagnostic pathway …

Context In the United States, 192 000 men were diagnosed as having prostate cancer in
2009, the majority with low-risk, clinically localized disease. Treatment of these cancers is …

Context Active surveillance (AS) is an important strategy to reduce prostate cancer
overtreatment. However, the optimal criteria for eligibility and predictors of progression while …

OBJECTIVE. The purpose of this article is to review the many evolving facets of MRI in the
evaluation of prostate cancer. We will discuss the roles of multiparametric MRI, including …